Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide.

PubWeight™: 2.08‹?› | Rank: Top 2%

🔗 View Article (PMC 209140)

Published in J Bacteriol on June 01, 1990

Authors

J N Weiser1, D J Maskell, P D Butler, A A Lindberg, E R Moxon

Author Affiliations

1: Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headington, United Kingdom.

Articles citing this

Short-sequence DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev (1998) 8.47

Organization of the bacterial chromosome. Microbiol Rev (1990) 6.01

Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02

Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08

Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med (1998) 2.65

Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev (1997) 2.42

DNA fingerprinting of Salmonella enterica subsp. enterica serovar typhimurium with emphasis on phage type DT104 based on variable number of tandem repeat loci. J Clin Microbiol (2003) 2.28

Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun (1997) 2.27

Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis (2013) 1.64

Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A (1999) 1.60

Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation. Infect Immun (2001) 1.53

Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae. Infect Immun (1990) 1.45

Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b. Infect Immun (1992) 1.38

Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun (2000) 1.33

DNA fingerprinting of Shiga-toxin producing Escherichia coli O157 based on Multiple-Locus Variable-Number Tandem-Repeats Analysis (MLVA). Ann Clin Microbiol Antimicrob (2003) 1.33

Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide. Infect Immun (1994) 1.31

Inversion-independent phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol (1993) 1.30

Antigenic diversity and gene polymorphisms in Haemophilus influenzae. Infect Immun (1998) 1.19

Histidine auxotrophy in commensal and disease-causing nontypeable Haemophilus influenzae. J Bacteriol (2007) 1.13

Cloning of a gonococcal DNA sequence that complements the lipooligosaccharide defects of Neisseria gonorrhoeae 1291d and 1291e. Infect Immun (1993) 1.08

Altered lipopolysaccharide characteristic of the I69 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn. J Bacteriol (1996) 1.04

Evidence for in vivo expression of transferrin-binding proteins in Haemophilus influenzae type b. Infect Immun (1992) 1.03

Use of chromosomal gene fusions to investigate the role of repetitive DNA in regulation of genes involved in lipopolysaccharide biosynthesis in Haemophilus influenzae. J Bacteriol (1992) 1.01

Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog (2012) 0.99

Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila. J Exp Med (1998) 0.96

Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus. BMC Microbiol (2010) 0.93

Adhesive activity of the haemophilus cryptic genospecies cha autotransporter is modulated by variation in tandem Peptide repeats. J Bacteriol (2010) 0.92

Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol (2000) 0.90

vrrB, a hypervariable open reading frame in Bacillus anthracis. J Bacteriol (2000) 0.89

Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats. Infect Immun (1993) 0.88

Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae. Infect Immun (2007) 0.85

A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein. J Bacteriol (2006) 0.85

Phase-variable restriction/modification systems are required for Helicobacter pylori colonization. Gut Pathog (2014) 0.83

The tetrasaccharide L-alpha-D-heptose1-->2-L-alpha-D-heptose1--> 3-L-alpha-D-heptose1-->(3-deoxy-D-manno-octulosonic acid) and phosphate in lipid A define the conserved epitope in Haemophilus lipopolysaccharides recognized by a monoclonal antibody. Infect Immun (1995) 0.82

PCR amplification of DNA sequences from nitrocellulose-bound, immunostained bacterial colonies. Nucleic Acids Res (1993) 0.81

Shielding of a lipooligosaccharide IgM epitope allows evasion of neutrophil-mediated killing of an invasive strain of nontypeable Haemophilus influenzae. MBio (2014) 0.80

Selection for phase variation of LOS biosynthetic genes frequently occurs in progression of non-typeable Haemophilus influenzae infection from the nasopharynx to the middle ear of human patients. PLoS One (2014) 0.79

Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide. Clin Vaccine Immunol (2014) 0.77

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08

A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11

Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16

Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene (1983) 44.52

Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science (1986) 21.33

Dideoxy sequencing method using denatured plasmid templates. Anal Biochem (1986) 17.34

Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol (1987) 15.79

Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol (1981) 12.25

Novel bacteriophage lambda cloning vector. Proc Natl Acad Sci U S A (1980) 8.97

Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J Bacteriol (1970) 8.51

Graphic methods to determine the function of nucleic acid sequences. Nucleic Acids Res (1984) 6.08

The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60

Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae. J Infect Dis (1983) 3.44

Surface-exposed protein antigens of the gonococcal outer membrane. Infect Immun (1981) 3.28

Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03

Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00

Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84

Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect Immun (1986) 2.84

Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes, and biotypes among Haemophilus influenzae type b from patients with meningitis in The Netherlands. J Infect Dis (1983) 2.51

Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids. J Biol Chem (1985) 2.48

Messenger RNA recognition in Escherichia coli: a possible second site of interaction with 16S ribosomal RNA. EMBO J (1988) 1.91

Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56

Oligonucleotide hybridization techniques. Methods Enzymol (1987) 1.38

Articles by these authors

Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04

The gal locus from Haemophilus influenzae: cloning, sequencing and the use of gal mutants to study lipopolysaccharide. Mol Microbiol (1992) 9.22

Evaluation of five test-kits-API, AuxoTab, Enterotube, PathoTec and R-B-for identification of Enterobacteriaceae. Med Microbiol Immunol (1974) 8.61

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41

Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50

Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94

Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80

Bacteriophage receptors. Annu Rev Microbiol (1973) 4.45

Titration of antibodies to salmonella O antigens by enzyme-linked immunosorbent assay. Infect Immun (1972) 4.13

PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol (1994) 4.08

Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet (1997) 3.69

Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60

The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60

Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55

DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc Natl Acad Sci U S A (1996) 3.38

The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis (1981) 3.24

Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03

Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol (1992) 3.03

Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03

Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00

Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J Clin Invest (1984) 2.94

Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol (1997) 2.91

Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet (1993) 2.88

Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science (2013) 2.87

Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84

Enzyme-linked immunosorbent assay (ELISA) for titration of antibodies against Brucella abortus and Yersinia enterocolitica. Acta Pathol Microbiol Scand C (1976) 2.77

Simple sequence repeats in the Helicobacter pylori genome. Mol Microbiol (1998) 2.75

Salmonella: immune responses and vaccines. Vet J (2001) 2.68

Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1988) 2.68

The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export. Mol Microbiol (1990) 2.49

Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell (1988) 2.49

Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae. Eur J Biochem (1981) 2.47

Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44

Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol (1990) 2.42

Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev (1997) 2.42

Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41

Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39

The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol (1991) 2.36

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis (1995) 2.31

A lethal role for lipid A in Salmonella infections. Mol Microbiol (1998) 2.30

Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol (1993) 2.26

Detection and quantitation of bacteremia in childhood. J Pediatr (1977) 2.21

Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 2.21

Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol (1995) 2.18

The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol Microbiol (2000) 2.13

Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis (1977) 2.09

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA (2000) 2.07

Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis (1983) 2.06

The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest (2001) 2.04

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03

The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol (1991) 2.03

Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 2.02

Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia. J Clin Microbiol (1979) 1.99

The role of a repetitive DNA motif (5'-CAAT-3') in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope alpha Gal(1-4)beta Gal. Mol Microbiol (1993) 1.98

Capsulation in distantly related strains of Haemophilus influenzae type b: genetic drift and gene transfer at the capsulation locus. J Bacteriol (1990) 1.98

Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect Immun (1987) 1.97

Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol (1989) 1.96

Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol (1994) 1.96

Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child (1989) 1.95

Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol (1995) 1.93

Phage typing of Shigella sonnei. Arch Immunol Ther Exp (Warsz) (1968) 1.90

Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A (1978) 1.88

Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol Microbiol (1999) 1.88

Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun (1995) 1.88

Rapid and sensitive detection of Salmonella (O:6,7) by immunomagnetic monoclonal antibody-based assays. J Immunol Methods (1991) 1.86

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA (2000) 1.83

Salmonella typhimurium mutants defective in UDP-D-galactose:lipopolysaccharide alpha 1,6-D-galactosyltransferase. Structural, immunochemical, and enzymologic studies of rfaB mutants. J Biol Chem (1983) 1.82

Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type I and type III:6,7,8 antigens, group 6 antigen, and a core epitope. Infect Immun (1986) 1.81

An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J Infect Dis (1987) 1.81

Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun (1983) 1.81

Etiological diagnosis of bacterial pneumonia by gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity. Scand J Infect Dis (1983) 1.79

Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol Microbiol (1996) 1.79

Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr (1986) 1.79

Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77

IgA1 proteases of Haemophilus influenzae: cloning and characterization in Escherichia coli K-12. Proc Natl Acad Sci U S A (1983) 1.77

Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc Natl Acad Sci U S A (1986) 1.76

Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb Pathog (1986) 1.75

Glycosyl transferases of O-antigen biosynthesis in Salmonella enterica: identification and characterization of transferase genes of groups B, C2, and E1. J Bacteriol (1993) 1.74

Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73

Absence in Helicobacter pylori of an uptake sequence for enhancing uptake of homospecific DNA during transformation. Microbiology (1999) 1.73

Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol Microbiol (1992) 1.72

Studies of a receptor for felix O-1 phage in Salmonella minnesota. J Gen Microbiol (1967) 1.71

Molecular characterization of the O-acetyl transferase gene of converting bacteriophage SF6 that adds group antigen 6 to Shigella flexneri. Mol Microbiol (1991) 1.71

Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun (1998) 1.69

Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis (1983) 1.68

Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67

Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol (1988) 1.67

Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.66

Quantitation of Salmonella O-antibodies in human sera by enzyme-linked immunosorbent assay (ELISA). Int Arch Allergy Appl Immunol (1975) 1.66

Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis (2000) 1.65

Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis (1995) 1.64

Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun (1999) 1.59

Indirect enzyme-linked immunosorbent assay for the quantitation of the type-specific antigen of Haemophilus influenzae b: a preliminary report. J Pediatr (1980) 1.59

Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J Clin Microbiol (1989) 1.58

Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56

Alteration of the cell wall of Haemophilus influenzae type b by transformation with cloned DNA: association with attenuated virulence. J Infect Dis (1985) 1.56

Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet (1992) 1.55

Concentration of chloramphenicol in the urine and blood in relation to renal function. Br Med J (1966) 1.55